You are here

Olam's Q2 earnings treble to S$94.7m

Factors: fall in minority interests, lower expenses, units' contributions


OLAM International's second-quarter earnings have trebled to S$94.7 million despite lower revenue and a net loss from changes in the valuation of biological assets.

The surge in profit attributable to shareholders was helped by a sharp drop in profit attributable to non-